Praxis Precision Medicines
Biotechnology Research • 
Boston, Massachusetts, United States • 101-200 Employees
Company overview
| Headquarters | 99 High Street, 30th Floor, Boston, MA 02110, US |
| Phone number | +16173008460 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Employees | 101-200 |
| Socials |
Key Contacts at Praxis Precision Medicines
John F. Peak
Director, Executive Development Program
Jessica Barry
Associate Director Clinical Operations
Doris Neville
Executive Director, Cmc Head Of Engineering And Commercialization
Amber Roberts
Senior Director, Clinical Quality
David B. Goldstein
Co-Founder
Matthew Marsh
Associate Director Of Information Technology
Saba Jafarpour
Associate Medical Director- Clinical Development
Dharit Patel
Director, Pharmacovigilance
Patricia Brown
Senior Director, Quality Operations, Cmc
William Motel
Senior Director Regulatory Affairs
Praxis Precision Medicines Email Formats
Praxis Precision Medicines uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@praxismedicines.com), used 53.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@praxismedicines.com | 53.1% |
{last name}{last name} | doedoe@praxismedicines.com | 25% |
{first name}{last name} | johndoe@praxismedicines.com | 12.5% |
{first initial}{second initial}{last name} | jodoe@praxismedicines.com | 3.1% |
{first initial} | j@praxismedicines.com | 3.1% |
About Praxis Precision Medicines
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance. Praxis is applying insights into the genetic mutations that drive excitation-inhibition imbalance in diseases to select biological targets for rare and more prevalent neurological disorders. We share a common vision of reshaping the human condition into a more freeing and fulfilled existence by developing high impact medicines for patients and families affected by and living with complex brain disorders. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum™, and antisense oligonucleotide (ASO) platform, Solidus™, using our understanding of shared biological targets and circuits in the brain.
Praxis Precision Medicines revenue & valuation
| Annual revenue | $7,765,000 |
| Revenue per employee | $48,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $24,900,000 |
| Total funding | $350,000,000 |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Praxis Precision Medicines has 88 employees across 14 departments.
Departments
Number of employees
Funding Data
Explore Praxis Precision Medicines's funding history, including investment rounds, total capital raised, and key backers.
Praxis Precision Medicines Tech Stack
Discover the technologies and tools that power Praxis Precision Medicines's digital infrastructure, from frameworks to analytics platforms.
Security
Analytics
JavaScript libraries
WordPress themes
Page builders
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Miscellaneous
Programming languages
Blogs
Australia
New Zealand
Japan
United Kingdom
Frequently asked questions
4.8
40,000 users
